Bruscky IS, Bruscky DMV, de Melo FL, Medeiros ZM, Correia CDC. Cerebral mansoni schistosomiasis: a systematic review of 33 cases published from 1989 to 2019.
Trans R Soc Trop Med Hyg 2021;
115:1410-1413. [PMID:
34037805 DOI:
10.1093/trstmh/trab067]
[Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2021] [Revised: 03/22/2021] [Accepted: 05/04/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND
We investigated the epidemiology, clinical presentation and outcomes of individuals affected by cerebral schistosomiasis.
METHODS
This systematic review was planned in accordance with current guidelines for performing comprehensive systematic reviews and meta-analysis, including the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline.
RESULTS
Most of patients presented with seizures (48.5%), which is a non-specific symptom despite its high prevalence. There was no specific clinical manifestation that could help the diagnosis, which was made in 69.7% by histopathological analysis of brain tissue.
CONCLUSIONS
Seizures are a non-specific symptom to diagnose patients with cerebral schistosomiasis and accurate clinical indicators need to be derived through further studies.
Collapse